BCTX
Briacell Therapeutics
BCTX
BCTX
18 hedge funds and large institutions have $12.3M invested in Briacell Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
5
Reduced
4
Closed
5
Calls
$3.2M
Puts
$116K
Net Calls
+$3.08M
Net Calls Change
-$2.38M
Top Buyers
1 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
+$1.45M |
2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$231K |
3 |
TSS
Two Sigma Securities
New York
|
+$60.2K |
4 |
N
Natixis
Paris,
France
|
+$56.3K |
5 |
![]()
Simplex Trading
Chicago,
Illinois
|
+$50.9K |